Gland Pharma, Lupin, Dr Reddy's: All Nifty Pharma Stocks In Red After Trump's Drug Tariff Plan

The Nifty Pharma index was down 1.32% in early trade at 25,747.60, with all 19 constituents trading in the red as investors reassessed the potential long-term impact of higher US tariffs on Indian drug exporters.